WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004005279) SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/005279    International Application No.:    PCT/US2003/021601
Publication Date: 15.01.2004 International Filing Date: 09.07.2003
Chapter 2 Demand Filed:    05.02.2004    
IPC:
C07D 209/20 (2006.01), C07D 213/36 (2006.01), C07D 215/12 (2006.01), C07D 217/02 (2006.01), C07D 401/12 (2006.01), C07D 403/12 (2006.01), C07D 405/12 (2006.01), C07D 413/12 (2006.01), C07D 417/12 (2006.01), C07D 471/04 (2006.01), C07D 471/12 (2006.01), C07D 487/04 (2006.01)
Applicants: AMGEN INC. [US/US]; One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (US)
Inventors: HUANG, Qi; (US).
CHEN, Guoqing; (US).
LI, Aiwen; (US).
RIAHI, Babak; (US).
TASKER, Andrew; (US).
YANG, Kevin; (US).
YUAN, Chester, Chenguang; (US)
Agent: ODRE, Steven, M.; Amgen Inc., One Amgen Center Drive, M/S 27-4-A, Thousand Oaks, CA 91320-1799 (US)
Priority Data:
60/395,144 09.07.2002 US
10/615,809 08.07.2003 US
Title (EN) SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE
(FR) DERIVES D'AMIDE ANTHRANILIQUE SUBSTITUES ET LEURS PROCEDES D'UTILISATION
Abstract: front page image
(EN)Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
(FR)Les composés sélectionnés sont efficaces dans la prévention et le traitement de maladies, dont les maladies induites par l'angiogenèse. L'invention concerne de nouveaux composés, analogues, promédicaments et leurs sels pharmaceutiquement acceptables, compositions pharmaceutiques et procédés de prévention et de traitement de maladies et d'autres troubles ou états pathologiques ayant trait au cancer et analogue. L'invention concerne également des procédés d'obtention de tels composés ainsi que des intermédiaires que l'on utilise dans de tels procédés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)